0
Views
3
CrossRef citations to date
0
Altmetric
Debate

The 2012 University of Cape Town Faculty of Health Sciences centenary debate

“Cholesterol is not an important risk factor for heart disease, and the current dietary recommendations do more harm than good”

References

  • Cordain L, Miller JB, Eaton SB, et al. Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am J Clin Nutr. 2000;71(3):682–692.
  • Boyd Eaton S, Konner M. Paleolithic nutrition: a consideration of its nature and current implications. New Eng J Med. 1985;312(5):283–289.
  • Konner M, Eaton SB. Paleolithic nutrition: twenty-five years later. Nutr Clin Pract. 2010;25(6):594–602.
  • Heinrich B. Endurance predator. In: Sands RR, Sands LR, editors. The anthropology of sport and human movement. Maryland: Lexington Books, 2010; p. 95–101.
  • Noakes TD. Thermoregulation and hydrating stategies in human evolution. In: Sands RR, Sands LR, editors. The anthropology of sport and human movement. Maryland: Lexington Books, 2010; p. 103–141.
  • Sands RR. Homo cursor: running into the pleistocene. In: Sands RR, Sands LR, editors. The anthropology of sport and human movement. Maryland: Lexington Books, 2010; p. 143–181.
  • Wrangham R. Catching fire: how cooking made us human. New York: Basic Books, 2009; p. 1–309.
  • Wilkins J, Schoville BJ, Brown KS, Chazan M. Evidence for early hafted hunting technology. Science. 2012;338(6109): 942–946.
  • Ben-Dor M, Gopher A, Hershkovitz I, Barkai R. Man the fat hunter: the demise of Homo erectus and the emergence of a new hominin lineage in the Middle Pleistocene (ca. 400 kyr) Levant. PLoS One. 2011;6(12):e28689.
  • Steckel RH, Prince JM. Tallest in the world: native Americans of the Great Plains in the nineteenth century. Am Econ Rev. 2001;91(1):287–294.
  • Catlin G. North American Indians. Philadelphia: Leary, Stuart and Company, 1913; p. 1–303.
  • Story M, Evans M, Fabsitz RR, et al. The epidemic of obesity in American Indian communities and the need for childhood obesity-prevention programs. Am J Clin Nutr. 1999;69(4 Suppl): 747S-754S.
  • Campbell GD. Diabetes in Asians and Africans in and around Durban. S Afr Med J. 1963;37:1195–1208.
  • Campbell GD. Incidence of diabetes mellitus in one district of Basutoland. S Afr Med J. 1960;34:332.
  • Campbell GD, Batchelor EL, Goldberg MD. Sugar intake and diabetes. Diabetes. 1967;16(1):62–63.
  • Cohen AM, Bavly S, Poznanski R. Change of diet of Yemenite Jews in relation to diabetes and ischaemic heart-disease. Lancet. 1961;2(7217):1399–1401.
  • Cohen AM. Fats and carbohydrates as factors in atheroclerosis and diabetes in Yemenite Jews. Am Heart J. 1963;65:291–293.
  • Yam D, Eliraz A, Berry EM. Diet and disease: the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci. 1996;32(11):1134–1143.
  • Minger D. Death by food pyramid. New York: Primal Nutrition, 2014; p. 1–300.
  • Teicholz N. The big fat surprise. New York: Simon & Schuster, 2014; p. 1–479.
  • Taubes G. Good calories, bad calories. New York: Anchor Books, 2007; p. 1–609.
  • Keys A. Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp NY. 1953;20(2):118–139.
  • Mayosi BM, Forrester T. Commentary: “Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda” by AG Shaper and KW Jones. Int J Epidemiol 2012;41(5):1233–1235.
  • Yerushalmy J, Hilleboe HE. Fat in the diet and mortality from heart disease; a methodologic note. NY State J Med. 1957;57(14):2343–2354.
  • Yudkin J. Diet and coronary thrombosis hypothesis and fact. Lancet. 1957;273(6987):155–162.
  • Yudkin J, Roddy J. Levels of dietary sucrose in patients with occlusive atherosclerotic disease. Lancet. 1964;2(7349):6–8.
  • Yudkin J. Dietary fat and dietary sugar in relation to ischaemic heart-disease and diabetes. Lancet. 1964;2(7349):4–5.
  • Armstrong BK, Mann JI, Adelstein AM, Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chronic Dis. 1975;28(9):455–469.
  • Harper AE. Coronary heart disease: an epidemic related to diet? Am J Clin Nutr. 1983;37(4):669–681.
  • Page IH, Stare FJ, Corcoran AC, et al. Atherosclerosis and the fat content of the diet. Circulation. 1957;16(2):163–178.
  • Dietary fat and its relation to heart attacks and strokes. Report by the Central Committee for Medical and Community Program of the American Heart Association. JAMA. 1961;175:389–391.
  • Michaels D. Doubt is their product. New York: Oxford Univ Press, 2008; p. 1–372.
  • Taubes G, Couzens CK. Sweet little lies. Mother Jones. 2012;35-40,68–69.
  • Cleave TL, Campbell GD. The saccharine disease. Am J Proctol. 1967;18(3):202–210.
  • Cleave TL, Campbell GD. Diabetes, coronary thrombosis and the saccharine disease. Bristol: John Wright & Sons, 1966; p. 1–146.
  • Yudkin J. Sugar and disease. Nature. 1972;239(5369):197–199.
  • Yudkin J. Pure, white and deadly. London: Penguin Books, 1972; p. 1–200.
  • Gillespie D. Sweet poison: why sugar makes us fat. Victoria: Viking, 2008; p. 1–208.
  • Lustig RH, Schmidt LA, Brindis CD. Public health: the toxic truth about sugar. Nature. 2012;482(7383):27–29.
  • Lustig RH. Fat chance: beating the odds against sugar, processed food, obesity and disease. New York: Hudson Street Press, 2013; p. 1–320.
  • Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One. 2013;8(2):e57873.
  • O’Connell J. Sugar nation. New York: Hyperion, 2011; p. 1–303.
  • Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000;343(8):530–537.
  • Horowitz R. Putting meat on the American table. Baltimore: John Hopkins University Press, 2006; p. 1–160.
  • Rose G, Marmot MG. Social class and coronary heart disease. Br Heart J. 1981;45(1):13–19.
  • Peretti J. Why our food is making us fat. The Guardian [homepage on the Internet]. 2012. Available from: http://www.theguardian.com/business/2012/jun/11/why-our-food-is-making-us-fat
  • Ahrens EH. Dietary fats and coronary heart disease: unfinished business. Lancet. 1979;2(8156-8157): 1345–1348.
  • Responses to dietary goals for the United States. Nutrition Today. 1977;12(6):10-13, 20–27.
  • Reiser R. Oversimplification of diet: coronary heart disease relationships and exaggerated diet recommendations. Am J Clin Nutr. 1978 May;31(5):865–875.
  • Hite AH, Feinman RD, Guzman GE, et al. In the face of contradictory evidence: report of the Dietary Guidelines for Americans Committee. Nutrition. 2010;26(10): 915–924.
  • Hoenselaar R. Further response from Hoenselaar. Br J Nutr. 2012;108(5):939–942.
  • Puaschitz NG, Strand E, Norekval TM, et al. Dietary intake of saturated fat is not associated with risk of coronary events or mortality in patients with established coronary artery disease. J Nutr. 2015;145(2):299–305.
  • Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.
  • Malhotra A. Saturated fat is not the major issue. BMJ. 2013;347:f6340.
  • Hooper L, Summerbell CD, Thompson R, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Review. In: The Cochrane Library, Issue 5, 2012. Oxford: Update Software.
  • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535–546.
  • Hoenselaar R. Saturated fat and cardiovascular disease: the discrepancy between the scientific literature and dietary advice. Nutrition. 2012;28(2):118–123.
  • Astrup A, Dyerberg J, Elwood P, et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr. 2011;93(4):684–688.
  • Ravnskov U, DiNicolantonio JJ, Harcombe Z, et al. The questionable benefits of exchanging saturated fat with polyunsaturated fat. Mayo Clin Proc. 2014;89(4):451–453.
  • Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010;104(11):1586–1600.
  • DiNicolantonio JJ. The cardiometabolic consequencwes of replacing saturated fats with carbohydrates or omega-6 polyunsaturated fats: do the dietary guidelines have it wrong? Open Heart. 2014;1(1):e00032.
  • Ravnskov U. The fallacies of the lipid hypothesis. Scand Cardiovasc J. 2008;42(4):236–239.
  • Castelli WP. Concerning the possibility of a nut. Arch Intern Med. 1992;152(7):1371–1372.
  • Harvard. Fats and cholesterol: out with the bad, in with the good. The Nutrition Source [homepage on the Internet]. 2014. Available from: http://www.hsph.harvard.edu/nutritionsource/fats-full-story/
  • Stock AL, Yudkin J. Nutrient intake of subjects on low carbohydrate diet used in treatment of obesity. Am J Clin Nutr. 1970;23(7):948–952.
  • Willett WC. Is dietary fat a major determinant of body fat? Am J Clin Nutr. 1998;67(3 Suppl):556S-562S.
  • Taubes G. Why we get fat: the diet/weight relationship: an alternative hypothesis. YouTube [homepage on the Internet]. c2015. Available from: https://www.youtube.com/watch?v=qEuIlQONcHw
  • Petersen KF, Dufour S, Savage DB, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA. 2007;104(31):12587–12594.
  • Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM. Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care. 1989;12(2):94–101.
  • Kraemer FB, Ginsberg HN. Gerald M. Reaven, MD: Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease. Diabetes Care. 2014;37(5):1178–1181.
  • Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32(8):1754–1759.
  • Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77(1):43–50.
  • Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014;349:g4596.
  • Bierman EL, Hamlin JT, III. The hyperlipemic effect of a low-fat, high-carbohydrate diet in diabetic subjects. Diabetes. 1961;10:432–437.
  • Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96(4):727–734.
  • Guldbrand H, Dizdar B, Bunjaku B, et al. In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia. 2012;55(8):2118–2127.
  • Sestoft L, Krarup T, Palmvig B, et al. High-carbohydrate, low-fat diet: effect on lipid and carbohydrate metabolism, GIP and insulin secretion in diabetics. Dan Med Bull. 1985;32(1):64–69.
  • Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes. 1992;41(10):1278–1285.
  • Frost G, Leeds AA, Dore CJ, et al. Glycaemic index as a determinant of serum HDLcholesterol concentration. Lancet. 1999;353(9158):1045–1048.
  • Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260(13):1917–1921.
  • Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106(2):241–253.
  • Miselli MA, Nora ED, Passaro A, et al. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study. Cardiovasc Diabetol. 2014;13(1):135.
  • De Graaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 1991;11(2): 298–306.
  • Freedman DS, Otvos JD, Jeyarajah EJ, et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem. 2004;50(7):1189–1200.
  • Liu S, Manson JE, Buring JE, et al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002;75(3):492–498.
  • Flannery C, Dufour S, Rabol R, et al. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes. 2012;61(11):2711–2717.
  • Ahmed N, Babaei-Jadidi R, Howell SK, et al. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care. 2005;28(10):2465–2471.
  • Toma L, Stancu CS, Botez GM, et al. Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem Biophys Res Commun. 2009;390(3): 877–882.
  • Yano M, Hasegawa G, Ishii M, et al. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep. 2004;9(2):111–116.
  • Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab. 2003;88(6):2422–2429.
  • Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008–3011.
  • Bosse JD, Lin HY, Sloan C, et al. A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance. Am J Physiol Heart Circ Physiol. 2013;304(12):H1733-H1742.
  • Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology. 2012;79(10):1019–1026.
  • Kerti L, Witte AV, Winkler A, et al. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology. 2013;81(20):1746–1752.
  • Seneff S, Wainwright G, Mascitelli L. Nutrition and Alzheimer’s disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med. 2011;22(2):134–140.
  • Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1561):9–16.
  • Meyerhardt JA, Sato K, Niedzwiecki D, et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012;104(22):1702–1711.
  • Romieu I, Ferrari P, Rinaldi S, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2012;96(2):345–355.
  • Stattin P, Bjor O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30(3):561–567.
  • Moynihan R, Cassels A. Selling sickness: how the world’s biggest pharmaceutical companies are turning us all into patients. New York: Nation Books, 2005; p. 1–254.
  • Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013;347:f6123.
  • Di AE, Gao P, Pennells L, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012;307(23):2499–2506.
  • Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009;157(1):111–117.
  • Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256(20):2835–2838.
  • Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 1996;124 Suppl:S1-S9.
  • Ware WR. The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression. Med Hypotheses. 2009;73(4):596–600.
  • Ravnskov U. Is atherosclerosis caused by high cholesterol? QJM. 2002;95(6):397–403.
  • Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311(3):271–278.
  • West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 1983;6(4):361–369.
  • Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322(7277):15–18.
  • Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413–420.
  • Schilling S, Tzourio C, Dufouil C, et al. Plasma lipids and cerebral small vessel disease. Neurology. 2014;83(20):1844–1852.
  • Feinman RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31(1):1–13.
  • Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625.
  • Benn M, Tybjaerg-Hansen A, McCarthy MI, et al. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study. J Am Coll Cardiol. 2012;59(25):2356–2365.
  • Shaye K, Amir T, Shlomo S, Yechezkel S. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J. 2012;164(1):111–116.
  • Westman EC, Phinney SD, Volek JS. The new Atkins for a new you. New York: Fireside, 2010; p. 1–330.
  • Volek JS, Phinney SD. The art and science of low carbohydrate performance. Florida: Beyond Obesity LLC, 2012; p. 1–162.
  • Volek JS, Phinney SD. The art and science of low carbohydrate living. Florida: Beyond Obesity LLC, 2011; p. 1–302.
  • Gunnars K. 23 studies on low-carb and low-fat diets: time to retire the fad. Authority Nutrition [homepage on the Internet]. 2013. Available from: http://authoritynutrition.com/23-studies-on-low-carb-and-low-fat-diets/
  • Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. New Eng J Med. 2003;348(21):2082–2090.
  • Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. New Eng J Med. 2003;348(21):2074–2081.
  • Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr. 2003;142(3):253–258.
  • Brehm BJ, Seeley RJ, Daniels SR, D’Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88(4):1617–1623.
  • Aude YW, Agatston AS, Lopez-Jimenez F, et al. The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial. Arch Intern Med. 2004;164(19):2141–2146.
  • Yancy WS Jr, Olsen MK, Guyton JR, et al. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004;140(10):769–777.
  • Volek J, Sharman M, Gomez A, et al. Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutr Metab (Lond). 2004;1(1):13.
  • Meckling KA, O’Sullivan C, Saari D. Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J Clin Endocrinol Metab. 2004;89(6):2717–2723.
  • Nickols-Richardson SM, Coleman MD, Volpe JJ, Hosig KW. Perceived hunger is lower and weight loss is greater in overweight premenopausal women consuming a lowcarbohydrate/high-protein vs high-carbohydrate/low-fat diet. J Am Diet Assoc. 2005;105(9):1433–1437.
  • Daly ME, Paisey R, Paisey R, et al. Short-term effects of severe dietary carbohydraterestriction advice in type 2 diabetes: a randomized controlled trial. Diabet Med. 2006;23(1):15–20.
  • McClernon FJ, Yancy WS Jr, Eberstein JA, et al. The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring). 2007;15(1):182–187.
  • Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A to Z Weight Loss Study: a randomized trial. JAMA. 2007;297(9):969–977.
  • Halyburton AK, Brinkworth GD, Wilson CJ, et al. Low- and high-carbohydrate weightloss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr. 2007;86(3):580–587.
  • Dyson PA, Beatty S, Matthews DR. A low-carbohydrate diet is more effective in reducing body weight than healthy eating in both diabetic and non-diabetic subjects. Diabet Med. 2007;24(12):1430–1435.
  • Westman EC, Yancy WS Jr, Mavropoulos JC, et al. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008;5:36.
  • Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229–241.
  • Keogh JB, Brinkworth GD, Noakes M, et al. Effects of weight loss from a very-lowcarbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87(3):567–576.
  • Tay J, Brinkworth GD, Noakes M, et al. Metabolic effects of weight loss on a very-lowcarbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol. 2008;51(1):59–67.
  • Volek JS, Phinney SD, Forsythe CE, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44(4):297–309.
  • Brinkworth GD, Noakes M, Buckley JD, et al. Long-term effects of a very-lowcarbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009;90(1):23–32.
  • Hernandez TL, Sutherland JP, Wolfe P, et al. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr. 2010;91(3):578–585.
  • Krebs NF, Gao D, Gralla J, et al. Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents. J Pediatr. 2010;157(2):252–258.
  • Volek JS, Fernandez ML, Feinman RD, Phinney SD. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res. 2008;47(5):307–318.
  • Bazzano LA, Hu T, Reynolds K, et al. Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med. 2014;161(5):309–318.
  • Dreon DM, Fernstrom HA, Campos H, et al. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr. 1998;67(5):828–836.
  • Krauss RM, Blanche PJ, Rawlings RS, et al. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83(5):1025–1031.
  • Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr. 2001;131(2):340S-343S.
  • Faghihnia N, Tsimikas S, Miller ER, et al. Changes in lipoprotein (a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. J Lipid Res. 2010;51(11):3324–3330.
  • Volk BM, Kunces LJ, Freidenreich DJ, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS One. 2014;9(11):e113605.
  • Santos FL, Esteves SS, da Costa PA, et al. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev. 2012;13(11):1048–1066.
  • Hu T, Mills KT, Yao L, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176 Suppl 7:S44-S54.
  • Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51(6):931–938.
  • Howard BV, Van HL, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women;s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):655–666.
  • Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis. 1999;20(12):2209–2218.
  • Michels KB, Willett WC. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial: a post-mortem. Breast Cancer Res Treat. 2009;114(1):1–6.
  • Noakes TD. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial: an inconvenient finding and the diet-heart hypothesis. S Afr Med J. 2013;103(11):824–825.
  • Noakes TD. WHIDMT: Rossouw and Howard blatantly miss the point. S Afr Med J. 2014;104(4):261–262.
  • Rossouw JE, Howard BV. Noakes misses the point. S Afr Med J. 2013,103(123):882 [homepage on the Internet. Available from: http://www.samj.org.za/index.php/samj/article/view/7709/5668
  • Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004;80(5):1175–1184.
  • Knopp RH, Retzlaff BM. Saturated fat prevents coronary artery disease? An American paradox. Am J Clin Nutr. 2004;80(5):1102–1103.
  • Westman EC, Yancy WS Jr, Olsen MK, et al. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol 2006 Jun 16; 110(2): 212–216.
  • Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997 Aug 22; 272(34): 20963–20966.
  • Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Kimoto E, Koyama H, et al. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis. 2009;202(2):582–588.
  • Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–1077.
  • St-Pierre AC, Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25(3):553–559.
  • Shikany JM, Margolis KL, Pettinger M, et al. Effects of a low-fat dietary intervention on glucose, insulin and insulin resistance in the Women’s Health Initiative (WHI) Dietary Modification trial. Am J Clin Nutr. 2011;94(1):75–85.
  • Halton TL, Liu S, Manson JE, Hu FB. Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr. 2008;87(2):339–346.
  • Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–1575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.